|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
����ø���Ƽ� |
| ��������������� | |
|
������ |
|
�ƻ� |
|
��� |
| PubMed | |
|
Article by Yu,D.Q |
|
Article by Tang,h |
|
Article by Xu,J.H |
����ݡ��������Ѫ���Ƶ��о���չ
������1,�ƻ�2,���3
1. ��ɽҽԺ
2. ������ѧ������ɽҽԺƤ����
3. �Ϻ�������ѧ������ɽҽԺƤ����
��Ѫ����������ݡ����ķ�����������Ҫ�����á��ڡ���Դ����Ѫ;��ͬʱ�����������Ѫø����Ѫø��һ�ֵ���ø�������弤���������յ��ʴ�ϸ���ͷ��鰷���Ӷ��շ�ݡ����ķ������䲡��������������Ѫ�������������߶����ء�����ҩ�Ｐ����ø���Ƽ��Բ���������ݡ������һ����Ч�����������������Ѫ������������ݡ������о���չ��
Chronic urticaria and blood coagulation mechanism
Blood coagulation plays an important role in the pathogenesis of chronic urticaria. Both the intrinsic and extrinsic pathways of the coagulation cascade are activated in chronic urticaria, which in turn induce the generation of thrombin. Thrombin, as the agonist of proteinase-activated receptors, can induce histamine release from mast cells, and then cause the development of urticaria. The severity of urticaria is parallel to the quantity of coagulation factors. Anticoagulants and protease inhibitors have shown certain efficacy in the treatment of some refractory urticaria. This paper summarizes recent progress in the development of blood coagulation-targeting strategies for the treatment of chronic urticaria.